Serum ca 50 as a tumor marker in pancreatic cancer: A comparison with CA 19-9
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Reference18 articles.
1. Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19-9.
2. The use of CA-50 radioimmunoassay in differentiating benign and malignant pancreatic disease
3. Gastrointestinal cancer-associated antigen CA 19-9 in histological specimens of pancreatic tumours and pancreatitis
4. Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer
5. Tissue expression of the tumor marker CA 50 in benign and malignant pancreatic lesions. A comparison with CA 19-9
Cited by 54 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Diagnostic value of carbohydrate antigen CA50, carbohydrate antigen 19-9 and α-fetoprotein in biliary tract cancer: A large-scale multicenter study;2023-09-14
2. Carbohydrate Antigen 50: Values for Diagnosis and Prognostic Prediction of Intrahepatic Cholangiocarcinoma;Medicina;2020-11-16
3. Development of novel diagnostic system for pancreatic cancer, including early stages, measuring mRNA of whole blood cells;Cancer Science;2019-03-27
4. CA242 as a biomarker for pancreatic cancer and other diseases;Progress in Molecular Biology and Translational Science;2019
5. Distinct serum metabolomics profiles associated with malignant progression in the KrasG12Dmouse model of pancreatic ductal adenocarcinoma;BMC Genomics;2015-01-15
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3